Tevogen Inc. Warrants (TVGNW) Live Share Price, Invest From India

Tevogen Inc. Warrants Stock Performance

as on August 13, 2026 at 2:32 am IST

Day's Low
Day's High
$0.05
Day's Price Range
$0.05
$0.05
-5.26%
Downside
5.26%
Upside
52 Week's Low
52 Week's High
$0.03
52-Week Price Range
$0.08
$0.05
46.74%
Downside
68.00%
Upside

Tevogen Inc. Warrants share price movements today

Previous Close: $0.05
Open: $0.05
Volume: 4.3K
Day's Low - High: $0.05 - $0.05
52 Week Low - High: $0.03 - $0.08

Tevogen Inc. Warrants Historical Returns

1 Month Return: -7.32 %
3 Month Return: + 49.57 %
1 Year Return: -25.75 %
3 Year Return: 0 %
5 Year Return: 0 %

Tevogen Inc. Warrants Stock Fundamentals & Key Indicators

Check Tevogen Inc. Warrants market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

0.00%

Tevogen Inc. Warrants vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tevogen Inc. Warrants with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Tevogen Inc. Warrants	NA	$-	NA	NA	0.00%	NA
Insmed Inc.	BUY	$29.0B	454.22%	NA	-76.94%	NA
Alnylam Pharmaceuticals Inc.	BUY	$29.0B	10.09%	38.2	16.13%	NA
Vertex Pharmaceuticals Inc.	BUY	$132.8B	171.88%	28.9	35.00%	NA
Regeneron Pharmaceuticals Inc.	BUY	$83.2B	31.09%	19.42	27.87%	0.45999999999999996%

Stock Returns calculator for Tevogen Inc. Warrants Stock including INR - Dollar returns

The Tevogen Inc. Warrants stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Tevogen Inc. Warrants investment value today

Current value as on today

₹73,832

Returns

-₹26,168

(-26.17%)

Returns from Tevogen Inc. Warrants Stock

-₹32,143 (-32.14%)

Dollar Impact

₹5,975 (+5.98%)

Indian Investors' Interest in Tevogen Inc. Warrants Stock

Search interest for Tevogen Inc. Warrants Stock has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.

Time period: July 13, 2026 to August 12, 2026

Change:-49% versus previous 30 day period

Tevogen Inc. Warrants Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	0	-	-	-	-
Gross Profit	0	0	0	0	-	0	0	0	0	0
Operating Income	-2	-29	-8	-6	-9	-10	-5	-5	-4	-5
EBITDA	-3	11	-9	-5	-	-10	-5	-5	-4	-5
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	-3	11	-9	-5	-9	-10	-5	-5	-4	-5
Income Tax Expense	0	48	-3	-5	-	0	-	-	-	-
Net Income	-3	11	-6	-5	-9	-10	-5	-5	-4	-5
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-2614.08%	0.00%	0.00%	0.00%	0.00%

Tevogen Inc. Warrants Annual Profit & Loss

All numbers in Millions USD

	Jun 2022	Jun 2023	Jun 2024	Jun 2025	Jun 2026
Total Revenue	-	-	-	-	-
Gross Profit	-	-	0	0	-
Operating Income	-4	0	-8	-53	-26
EBITDA	-14	4	-58	-13	-25
Interest Expense	0	-	0	0	0
Depreciation	0	0	0	0	0
Income Before Tax	-15	4	-60	-13	-26
Income Tax Expense	-9	0	0	-	-
Net Income	-15	4	-60	-10	-26
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

Tevogen Inc. Warrants Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	11	-9	-5	-9	-10	-5	-5	-4	-5
Operating Cash Flow	-2	-2	-3	-3	-3	-3	-3	-2	-2
Investing Cash Flow	-	-	-	-	-	-	-	0	-
Financing Cash Flow	2	2	5	2	4	1	4	1	2
Change in Cash	0	0	1	-1	0	-1	0	0	0

Tevogen Inc. Warrants Annual Cash Flow

All numbers in Millions USD

	Jun 2023	Jun 2024	Jun 2025	Jun 2026
Net Income	-22	-60	-13	-26
Operating Cash Flow	-8	-8	-11	-12
Investing Cash Flow	0	0	-	0
Financing Cash Flow	7	3	12	11
Change in Cash	-1	-4	0	0

Insights on Tevogen Inc. Warrants

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 152.5% return, outperforming this stock by 164.9%
NEGATIVE IMPACT
Price Dip
In the last 7 days, TVGNW stock has moved down by -14.1%

About Tevogen Inc. Warrants

Tevogen Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in Phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 patients with a B cell cancer indication, as well as Long COVID prevention and treatment. It is also developing TVGN 920, a preclinical trial drug for treating cervical cancer; TVGN 960, a preclinical trial drug for treating oropharyngeal cancer; TVGN 601, a preclinical trial drug for treating multiple sclerosis; TVGN 930, a preclinical trial drug for treating Epstein-Barr virus associated lymphomas; and TVGN 116, a product candidate targeted at hepatitis B. It also offers artificial intelligence platform for drug development. Tevogen Inc. was formerly known as Tevogen Bio Holdings Inc. and changed its name to Tevogen Inc. in July 2026. The company was incorporated in 2020 and is headquartered in Warren, New Jersey.

Organisation	Tevogen Inc. Warrants
Headquarters	15 Independence Boulevard, Warren, NJ, United States, 07059
Industry	Miscellaneous
CEO	Dr. Ryan H. Saadi M.D., M.P.H.
E-voting on shares	Click here to vote

Key Management of Tevogen Inc. Warrants

Name	Title
Dr. Neal Flomenberg M.D.	Chief Scientific Officer and Global R&D Lead
Mr. Stephen Chen M.B.A.	Chief Technical Officer
Mr. Mittul Mehta	Chief Information Officer & Head of Tevogen.ai
Mr. Tapan V. Shah	Head of Investor Relations & Corporate Development
Mr. Sadiq Khan M.B.A.	Chief Commercial Officer & Interim Head of Tevogen Generics
Dr. Ryan H. Saadi M.D., M.P.H.	Co-Founder, CEO & Chairperson

FAQs

What is Tevogen Inc. Warrants share price today?

Tevogen Inc. Warrants share price today is $0.05 as on August 12, 2026 at 9:02 pm IST. Tevogen Inc. Warrants share today touched a day high of $0.05 and a low of $0.05.

What is the 52 week high and 52 week low for Tevogen Inc. Warrants share?

Tevogen Inc. Warrants share touched a 52 week high of $0.08 on August 15, 2025 and a 52 week low of $0.03 on March 4, 2026. Tevogen Inc. Warrants stock price today i.e. August 12, 2026 at 9:02 pm IST is trending at $0.05,which is 40.48% down from its 52 week high and 87.75% up from its 52 week low.

How to invest in Tevogen Inc. Warrants Stock (TVGNW) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tevogen Inc. Warrants on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tevogen Inc. Warrants Shares that will get you 31.5789 shares as per Tevogen Inc. Warrants share price of $0.05 per share as on August 12, 2026 at 9:02 pm IST.

What is the minimum amount required to buy Tevogen Inc. Warrants Stock (TVGNW) from India?

Indian investors can start investing in Tevogen Inc. Warrants (TVGNW) shares with as little as ₹95.32 or $1 (as of August 12, 2026 at 9:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹953.20 in Tevogen Inc. Warrants stock (as per the Rupee-Dollar exchange rate as on August 12, 2026 at 9:39 pm IST). Based on Tevogen Inc. Warrants share’s latest price of $0.05 as on August 12, 2026 at 9:02 pm IST, you will get 210.5263 shares of Tevogen Inc. Warrants. Learn more about fractional shares .